Polymer-xerogel composites for controlled release wound dressings

Biomaterials

Volumn 31, Issue 24, 2010, Pages 6336-6343

  Costache, Marius C ^a   Qu, Haibo ^b   Ducheyne, Paul ^b   Devore, David I ^a  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Composite; Controlled drug release; Polymer; Sol gel; Wound dressing

Indexed keywords

BUPIVACAINE; BURST RELEASE; CLINICAL APPLICATION; COMPOSITE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE; CYTOTOXIC; DRUG CONTENT; DRUG RELEASE KINETICS; DRUG-RELEASE RATE; IN-VITRO; LOCAL ANESTHETICS; MASS FRACTION; MICRO-PARTICLES; PHYSICAL INTEGRITY; THERAPEUTIC AGENTS; WEIGHT RATIOS; WOUND DRESSINGS;

AMINO ACIDS; ANESTHETICS; COPOLYMERIZATION; ETHERS; ETHYLENE; ETHYLENE GLYCOL; PHOSPHATASES; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; SILICON COMPOUNDS; SILICON OXIDES; SOL-GEL PROCESS; SOL-GELS; SOLS; TOXIC MATERIALS; XEROGELS;

POLYMERS;

BIOMATERIAL; BUPIVACAINE; COPOLYMER; LOCAL ANESTHETIC AGENT; MEPIVACAINE; MICROPARTICLE; MONOMER; POLYMER; SILICON DIOXIDE; TYROSINE POLY(ETHYLENE GLYCOL) DERIVED POLY(ETHER)CARBONATE COPOLYMER; UNCLASSIFIED DRUG; DELAYED RELEASE FORMULATION; GEL; MACROGOL DERIVATIVE; POLYCARBONATE-POLYETHER COPOLYMER; TYROSINE;

ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; CYTOTOXICITY; GEL; HISTOCOMPATIBILITY; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; INFLAMMATION; POROSITY; PRIORITY JOURNAL; SOLID; SUSTAINED DRUG RELEASE; WOUND DRESSING; XEROGEL; BANDAGE; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; HYDROLYSIS; KINETICS; MOLECULAR WEIGHT; PHARMACOLOGY; SOLUBILITY;

BANDAGES; BUPIVACAINE; DELAYED-ACTION PREPARATIONS; GELS; HYDROLYSIS; KINETICS; MEPIVACAINE; MOLECULAR WEIGHT; POLYETHYLENE GLYCOLS; POLYMERS; POROSITY; SILICON DIOXIDE; SOLUBILITY; TYROSINE;

EID: 77953650111     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.04.065     Document Type: Article

References (48)

1. Winter G.D. Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig. Nature 1962, 193:293-294.
2. Atiyeh B.S., Ioannovich J., Al-Amm C.A., El-Musa K.A. Management of acute and chronic open wounds: the importance of moist environment in optimal wound healing. Curr Pharm Biotechnol 2002, 3:179-195.
3. Higa O., Rogero S., Machado L., Mathor M., Lugao A. Biocompatibility study for PVP wound dressing obtained in different conditions. Radiat Phys Chem 1999, 55:705-707.
4. Khil M.S., Cha D.I., Kim H.Y., Kim I.S., Bhattarai N. Electrospun nanofibrous polyurethane membrane as wound dressing. J Biomed Mater Res B Appl Biomater 2003, 67B:675-679.
5. Mi F.L., Shyu S.S., Wu Y.B., Lee S.T., Shyong J.Y., Huang R.N. Fabrication and characterization of a sponge-like asymmetric chitosan membrane as a wound dressing. Biomaterials 2001, 22:165-173.
6. Yoshii F., Zhanshan Y., Isobe K., Shinozaki K., Makuuchi K. Electron beam crosslinked PEO and PEO/PVA hydrogels for wound dressing. Radiat Phys Chem 1999, 55:133-138.
7. Matthew I.R., Browne R.M., Frame J.W., Millar B.G. Subperiosteal behaviour of alginate and cellulose wound dressing materials. Biomaterials 1995, 16:275-278.
8. Doillon C.J., Silver F.H. Collagen-based wound dressing: effects of hyaluronic acid and fibronectin on wound healing. Biomaterials 1986, 7:3-8.
9. Loke W.K., Lau S.K., Yong L.L., Khor E., Sum C.K. Wound dressing with sustained anti-microbial capability. J Biomed Mater Res 2000, 53:8-17.
10. Mi F.L., Wu Y.B., Shyu S.S., Schoung J.Y., Huang Y.B., Tsai Y.H., et al. Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery. J Biomed Mater Res 2002, 59:438-449.
11. Lin S.Y., Chen K.S., Run-Chu L. Design and evaluation of drug-loaded wound dressing having thermoresponsive, adhesive, absorptive and easy peeling properties. Biomaterials 2001, 22:2999-3004.
12. Rastogi S., Modi M., Sathian B. The efficacy of collagen membrane as a biodegradable wound dressing material for surgical defects of oral mucosa: a prospective study. J Oral Maxillofac Surg 2009, 67:1600-1606.
13. Aoyagi S., Onishi H., Machida Y. Novel chitosan wound dressing loaded with minocycline for the treatment of severe burn wounds. Int J Pharm 2007, 330:138-145.
14. Ignatova M., Manolova N., Markova N., Rashkov I. Electrospun non-woven nanofibrous hybrid mats based on chitosan and PLA for wound-dressing applications. Macromol Biosci 2009, 9:102-111.
15. Lee S.Y., Oh J.H., Kim J.C., Kim Y.H., Kim S.H., Choi J.W. In vivo conjunctival reconstruction using modified PLGA grafts for decreased scar formation and contraction. Biomaterials 2003, 24:5049-5059.
16. Misra S.K., Valappil S.P., Roy I., Boccaccini A.R. Polyhydroxyalkanoate (PHA)/inorganic phase composites for tissue engineering applications. Biomacromolecules 2006, 7:2249-2258.
17. Yoo H.J., Kim H.D. Synthesis and properties of waterborne polyurethane hydrogels for wound healing dressings. J Biomed Mater Res B Appl Biomater 2008, 85B:326-333.
18. Kokabi M., Sirousazar M., Hassan Z.M. PVA-clay nanocomposite hydrogels for wound dressing. Eur Polym J 2007, 43:773-781.
19. Kong H., Jang J. Antibacterial properties of novel poly(methyl methacrylate) nanofiber containing silver nanoparticles. Langmuir 2008, 24:2051-2056.
20. Nicoll S.B., Radin S., Santos E.M., Tuan R.S., Ducheyne P. In vitro release kinetics of biologically active transforming growth factor-beta 1 from a novel porous glass carrier. Biomaterials 1997, 18:853-859.
21. Santos E.M., Radin S., Ducheyne P. Sol-gel derived carrier for the controlled release of proteins. Biomaterials 1999, 20:1695-1700.
22. Falaize S., Radin S., Ducheyne P. In vitro behavior of silica-based xerogels intended as controlled release carriers. J Am Ceram Soc 1999, 82:969-976.
23. Santos E.M., Radin S., Shenker B.J., Shapiro I.M., Ducheyne P. Si-Ca-P xerogels and bone morphogenetic protein act synergistically on rat stromal marrow cell differentiation in vitro. J Biomed Mater Res 1998, 41:87-94.
24. Radin S., Ducheyne P., Kamplain T., Tan B.H. Silica sol-gel for the controlled release of antibiotics. I. Synthesis, characterization, and in vitro release. J Biomed Mater Res 2001, 57:313-320.
25. Radin S., Ducheyne P. Controlled release of vancomycin from thin sol-gel films on titanium alloy fracture plate material. Biomaterials 2007, 28:1721-1729.
26. Radin S., Chen T., Ducheyne P. The controlled release of drugs from emulsified, sol gel processed silica microspheres. Biomaterials 2009, 30:850-858.
27. Radin S., Ducheyne P. Nanostructural control of implantable xerogels for the controlled release of biomolecules. Learning from nature how to design new implantable biomaterials: from biomineralization fundamentals to biomimetic materials and processing routes 2004, 59-74. Kluwer Academic Publishers, Netherlands. S.W.R.L. Reis (Ed.).
28. Ahola M., Kortesuo P., Kangasniemi I., Kiesvaara J., Yli-Urpo A. Silica xerogel carrier material for controlled release of toremifene citrate. Int J Pharm 2000, 195:219-227.
29. Barbe C., Bartlett J., Kong L., Finnie K., Lin H.Q., Larkin M., et al. Silica particles: a novel drug-delivery system. Adv Mater 2004, 16:1959-1966.
30. Coradin T., Boissiere M., Livage J. Sol-gel chemistry in medicinal science. Curr Med Chem 2006, 13:99-108.
31. Avnir D., Coradin T., Lev O., Livage J. Recent bio-applications of sol-gel materials. J Mater Chem 2006, 16:1013-1030.
32. Ahola M., Rich J., Kortesuo P., Kiesvaara J., Seppälä J., Yli-Urpo A. In vitro evaluation of biodegradable ε-caprolactone-co-D, L-lactide/silica xerogel composites containing toremifene citrate. Int J Pharm 1999, 181:181-191.
33. Frenning G., Tunon A., Alderborn G. Modelling of drug release from coated granular pellets. J Control Release 2003, 92:113-123.
34. Engelberg I., Kohn J. Physico-mechanical properties of degradable polymers used in medical applications: a comparative study. Biomaterials 1991, 12:292-304.
35. Yu C., Kohn J. Tyrosine-PEG-derived poly(ether carbonate)s as new biomaterials. Part I: synthesis and evaluation. Biomaterials 1999, 20:253-264.
36. Bourke S.L., Kohn J. Polymers derived from the amino acid L-tyrosine: polycarbonates, polyarylates and copolymers with poly(ethylene glycol). Adv Drug Deliv Rev 2003, 55:447-466.
37. Lai W., Garino J., Ducheyne P. Silicon excretion from bioactive glass implanted in rabbit bone. Biomaterials 2002, 23:213-217.
38. Radin S., El-Bassyouni G., Vresilovic E.J., Schepers E., Ducheyne P. In vivo tissue response to resorbable silica xerogels as controlled-release materials. Biomaterials 2005, 26:1043-1052.
39. Lai W., Garino J., Flaitz C., Ducheyne P. Excretion of resorption products from bioactive glass implanted in rabbit muscle. J Biomed Mater Res A 2005, 75A:398-407.
40. Pulapura S., Kohn J. Tyrosine-derived polycarbonates: backbone-modified " pseudo" -poly(amino acids) designed for biomedical applications. Biopolymers 1992, 32:411-417.
41. Topic Q2B. Validation of analytical procedures: methodology. In: Proceedings of the international conference on harmonization (ICH); November 1996.
42. Aughenbaugh W., Radin S., Ducheyne P. Silica sol-gel for the controlled release of antibiotics. II. The effect of synthesis parameters on the in vitro release kinetics of vancomycin. J Biomed Mater Res 2001, 57:321-326.
43. Siepmann J., Gopferich A. Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv Drug Deliv Rev 2001, 48:229-247.
44. Hancock B.C., York P., Rowe R.C. The use of solubility parameters in pharmaceutical dosage form design. Int J Pharm 1997, 148:1-21.
45. Marsac P.J., Shamblin S.L., Taylor L.S. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Pharm Res 2006, 23:2417-2426.
46. Sheihet L., Piotrowska K., Dubin R.A., Kohn J., Devore D. Effect of tyrosine-derived triblock copolymer compositions on nanosphere self-assembly and drug delivery. Biomacromolecules 2007, 8:998-1003.
47. Soriano I., Evora C. Formulation of calcium phosphates/poly (d,l-lactide) blends containing gentamicin for bone implantation. J Control Release 2000, 68:121-134.
48. Schnieders J., Gbureck U., Thull R., Kissel T. Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement. Biomaterials 2006, 27:4239-4249.